You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Acute Lymphoblastic Leukemia (ALL)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia (ALL) Trial (Nilotinib)

No longer available
  • Acute Lymphoblastic Leukemia (ALL)
  • (no location specified)
Aug 5, 2022

Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) Trial in Guediawaye GOL SUD (Pyronaridine Tetraphosphate)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Acute Lymphoblastic Leukemia (ALL)
  • Pyronaridine Tetraphosphate
  • Guediawaye GOL SUD, Dakar, Senegal
    Dalal Jamm Hospital
Nov 23, 2022

Acute Lymphoblastic Leukemia Trial in New York (Venetoclax)

Recruiting
  • Acute Lymphoblastic Leukemia
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 2, 2023

Acute Lymphoblastic Leukemia Trial (inotuzumab ozogamicin)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • inotuzumab ozogamicin
  • (no location specified)
Jan 6, 2023

Patients Who Received Inotuzumab Ozogamicin for B-cell ALL That

Not yet recruiting
  • Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
  • Inotuzumab Ozogamicin
  • (no location specified)
Nov 3, 2022

Acute Lymphoblastic Leukemia Trial in Tampa (Hyper CVAD Protocol (Standard of Care Multi-Agent Chemotherapy), Calaspargase

Recruiting
  • Acute Lymphoblastic Leukemia
  • Hyper CVAD Protocol (Standard of Care Multi-Agent Chemotherapy)
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Oct 12, 2022

Acute Lymphoblastic Leukemia, Hyperbilirubinemia Trial in Houston (Levocarnitine, Vitamin B Complex)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Hyperbilirubinemia
  • Levocarnitine
  • Vitamin B Complex
  • Houston, Texas
    M D Anderson Cancer Center
Nov 7, 2022

Vaccine Immune Recovery After Leukemia

Enrolling by invitation
  • Acute Lymphoblastic Leukemia, Pediatric
  • Observational only
  • Chicago, Illinois
  • +2 more
Nov 9, 2022

Lymphoid Leukemia Trial in Palo Alto (Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector

Not yet recruiting
  • Lymphoid Leukemia
  • Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector (CD19/CD22-BBz) chimeric antigen receptor (CAR)
  • Treg CD34+ HSPC (Orca-T)
  • Palo Alto, California
    Stanford Cancer Center
Aug 17, 2022

B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

Recruiting
  • B-Cell Lymphoblastic Leukemia
  • Acute Lymphoblastic Leukemia
  • Tampa, Florida
    Moffitt Cancer Center
Nov 28, 2023

Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)

Recruiting
  • Neoplasms
  • +2 more
  • RD13-02 cell infusion
  • Xuzhou, Jiangsu, China
    Affiliated hospital of Xuzhou medical college
Jun 7, 2023

Pediatric Acute Lymphoblastic Leukemia, Leukemia, Acute Lymphoblastic Leukemia Trial in Boston (Sleep ALL Night)

Not yet recruiting
  • Pediatric Acute Lymphoblastic Leukemia
  • +2 more
  • Sleep ALL Night
  • Boston, Massachusetts
  • +1 more
May 10, 2023

B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • HY004
  • +2 more
  • (no location specified)
Aug 18, 2023

Acute Lymphoblastic Leukemia (ALL) in Partial Remission, Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid

Recruiting
  • Acute Lymphoblastic Leukemia (ALL) in Partial Remission
  • +2 more
  • Riyadh, Saudi Arabia
    King Faisal Specialist Hospital & Research Center
Apr 4, 2022

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Frankfurt (Main) (Rituximab, Nelarabine, PEG-Asparaginase)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Frankfurt (Main), Germany
    University Hospital of Frankfurt (Main)
Jul 1, 2022

B Precursor Acute Lymphoblastic Leukemia, Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia Trial (Blinatumomab)

Not yet recruiting
  • B Precursor Acute Lymphoblastic Leukemia
  • Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia
  • (no location specified)
Sep 25, 2023

B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Azacitidine Injection
  • +2 more
  • (no location specified)
Oct 15, 2023

Adult Lymphoblastic Lymphoma Trial in Birmingham (Fludarabine, Total Body Irradiation)

Completed
Has Results
  • Adult Lymphoblastic Lymphoma
  • Birmingham, Alabama
    UAB Bone Marrow Transplantation and Cellular Therapy Program
Aug 23, 2022

T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

Not yet recruiting
  • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
  • CD7-CART01
  • (no location specified)
Sep 26, 2023

Infective Complications and Outcome of ALL Treated With INO

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
    • (no location specified)
    Aug 29, 2023

    Acute Lymphoblastic Leukemia Trial in Russian Federation (Lyophilized S95014)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Lyophilized S95014
    • Chelyabinsk, Russian Federation
    • +5 more
    Apr 25, 2022

    Acute Lymphoblastic Leukemia Trial in Memphis (Active tDCS, Sham tDCS)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Active tDCS
    • Sham tDCS
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Oct 27, 2021

    Precursor Cell Lymphoblastic Leukemia Trial in Germany (Inotuzumab ozogamicin)

    Recruiting
    • Precursor Cell Lymphoblastic Leukemia
    • Inotuzumab ozogamicin
    • Augsburg, Germany
    • +13 more
    Oct 31, 2022

    Lymphoblastic Leukemia, Acute, Adult, Ph Negative ALL, Newly Diagnosed Trial in Czechia (Blinatumomab)

    Active, not recruiting
    • Lymphoblastic Leukemia, Acute, Adult
    • +2 more
    • Brno, Czechia
    • +4 more
    Aug 3, 2022

    Pediatric ALL, B Cell, Minimal Residual Disease Trial in Seoul (Blinatumomab for Injection)

    Recruiting
    • Pediatric ALL, B Cell
    • Minimal Residual Disease
    • Blinatumomab for Injection
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Feb 20, 2022